SCHEMBL126497

SCHEMBL126497

O=C(ON1C(=O)CCC1=O)c1c(Cl)c(Cl)c2c(c1Cl)C1(OC2=O)c2cc(Cl)c(O)cc2Oc2c1cc(Cl)c(O)c2Cl

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 0.40
RECQL P46063 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
ALDH1A1 P00352 2/20 0.40
CYP3A4 P08684 1/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
CASP1 P29466 1/20 0.40
BRCA1 P38398 1/20 0.40
HIF1A Q16665 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MEN1 O00255 1/20 0.40
GLB1 P16278 1/20 0.40
BLM P54132 1/20 0.40
KMT2A Q03164 1/20 0.40
CTRC Q99895 1/20 0.40
SMAD3 P84022 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2472102 0.85 ALDH1A1 (0.45) THRBRECQLTDP1ALDH1A1CYP3A4
SCHEMBL4593779 0.80 THRB (0.41) THRBRECQLTDP1ALDH1A1CYP3A4
SCHEMBL29389278 0.80 THRB (0.41) THRBRECQLTDP1ALDH1A1CYP3A4
SCHEMBL5489541 0.79 SMAD3 (0.35) THRBRECQLTDP1ALDH1A1CYP3A4
SCHEMBL29838734 0.79 SMAD3 (0.35) THRBRECQLTDP1ALDH1A1CYP3A4
SCHEMBL29838717 0.79 SMAD3 (0.35) THRBRECQLTDP1ALDH1A1CYP3A4
SCHEMBL1444923 0.73 SMAD3 (0.57) THRBRECQLTDP1ALDH1A1CYP3A4
SCHEMBL1464049 0.72 SMAD3 (0.64) THRBRECQLTDP1ALDH1A1CYP3A4
SCHEMBL6843543 0.70 HPGD (0.46) THRBRECQLTDP1ALDH1A1CYP3A4
SCHEMBL1463198 0.67 SMAD3 (0.56) THRBRECQLTDP1ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9029091-B2 Procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line SYMPHOGEN A/S (DK) 2015-05-12 US disclosed
US-20130203063-A1 Procedure for Structural Characterization of a Recombinant Polyclonal Protein or a Polyclonal Cell Line SYMPHOGEN A/S (DK) 2013-08-08 US disclosed
US-20120322690-A1 Anti-Rhesus D Recombinant Polyclonal Antibody and Methods of Manufacture SYMPHOGEN A/S (DK) 2012-12-20 US disclosed
US-8288109-B2 Using proteolytic digestion as quality control tool in monitoring efficacy of products secreted from immunoglobulin producing cell line SYMPHOGEN A/S (DK) 2012-10-16 US disclosed
US-8198415-B2 Anti-rhesus D recombinant polyclonal antibody SYMPHOGEN A/S (DK) 2012-06-12 US disclosed
EP-2053408-B1 A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line SYMPHOGEN AS (DK) 2012-03-07 EP disclosed
EP-2053408-A2 A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line Symphogen A/S (DK) 2009-04-29 EP disclosed
US-20090017017-A1 Anti-rhesus d recombinant polyclonal antibody and methods of manufacture SYMPHOGEN A/S 2009-01-15 US disclosed
EP-1967529-A1 Anti-rhesus D recombinant polyclonal antibody and methods of manufacture Symphogen A/S (DK) 2008-09-10 EP disclosed
US-20080131882-A1 Procedure for Structural Characterization of a Recombinant Polylonal Protein or a Polyclonal Cell Line SYMPHOGEN A/S (DK) 2008-06-05 US disclosed
EP-1771483-A1 ANTI-RHESUS D RECOMBINANT POLYCLONAL ANTIBODY AND METHODS OF MANUFACTURE Symphogen A/S (DK) 2007-04-11 EP disclosed
WO-2006007850-A1 ANTI-RHESUS D RECOMBINANT POLYCLONAL ANTIBODY AND METHODS OF MANUFACTURE SYMPHOGEN A/S (DK) 2006-01-26 WO disclosed